EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Usefulness of medicine screening tools in the frame of pharmaceutical post-marketing surveillance

Christelle Ange Waffo Tchounga iD, Pierre-Yves Sacré iD, Raffaella Ravinetto, Marya Lieberman, Patient Hamuli Ciza, Rose Ngono Mballa, Eric Ziemons iD, Philippe Hubert, Roland Djang'eing'a Marini

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0289865 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Christelle Ange Waffo Tchounga und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Laboratory of Pharmaceutical Analytical Chemistry, University of Liege (ULiege), CIRM, Liège, Belgium. Hauptthemen laut MEDLINE: Counterfeit Drugs, Substandard Drugs. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Académie de recherche et d'enseignement supérieur.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The negative consequences of Substandard and falsified (SF) medicines are widely documented nowadays and there is still an urgent need to find them in more efficient ways. Several screening tools have been developed for this purpose recently. In this study, three screening tools were used on 292 samples of ciprofloxacin and metronidazole collected in Cameroon. Each sample was then analyzed by HPLC and disintegration tests. Seven additional samples from the nitro-imidazole (secnidazole, ornidazole, tinidazole) and the fluoroquinolone (levofloxacin, ofloxacin, norfloxacin, moxifloxacin) families were analyzed to mimic falsified medicines. Placebo samples that contained only inert excipients were also tested to mimic falsified samples without active pharmaceutical ingredient (API). The three screening tools implemented were: a simplified visual inspection checklist, a low-cost handheld near infrared (NIR) spectrophotometer and paper analytical devices (PADs). Overall, 61.1% of the samples that failed disintegration and assay tests also failed the visual inspection checklist test. For the handheld NIR, one-class classifier models were built to detect the presence of ciprofloxacin and metronidazole, respectively. The APIs were correctly identified in all the samples with sensitivities and specificities of 100%. However, the importance of a representative and up-to-date spectral database was underlined by comparing models built with different calibration set spanning different variability spaces. The PADs were used only on ciprofloxacin samples and detected the API in all samples in which the presence of ciprofloxacin was confirmed by HPLC. However, these PADs were not specific to ciprofloxacin since they reacted like ciprofloxacin to other fluoroquinolone compounds. The advantages and drawbacks of each screening tool were highlighted. They are promising means in the frame of early detection of SF medicines and they can increase the speed of decision about SF medicines in the context of pharmaceutical post-marketing surveillance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Counterfeit DrugsSubstandard DrugsHumansMetronidazoleCiprofloxacinLevofloxacinProduct Surveillance, Postmarketing

Substanzen

MetronidazoleCounterfeit DrugsSubstandard DrugsCiprofloxacinLevofloxacin

Autor:innen und Institutionen

  • Department of Pharmacy, Laboratory of Pharmaceutical Analytical Chemistry, University of Liege (ULiege), CIRM, Liège, Belgium.
  • Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon.
  • Department of Pharmacy, University of Liege (ULiege), CIRM, Research Support Unit in Chemometrics, Liège, Belgium.
  • Department of Public Health, Institute of Tropical Medicine Antwerp, Antwerp, Belgium.
  • School of Public Health, University of the Western Cape, Cape Town, South Africa.
  • Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, IN, United States of America.

ORCID-Profile: Christelle Ange Waffo Tchounga, Pierre-Yves Sacré, Eric Ziemons

Förderung

  • Académie de recherche et d'enseignement supérieur

Zitieren

APA

Waffo Tchounga, C. A., Sacré, P. Y., Ravinetto, R., Lieberman, M., Hamuli Ciza, P., Ngono Mballa, R., Ziemons, E., Hubert, P., & Djang'eing'a Marini, R. (2023). Usefulness of medicine screening tools in the frame of pharmaceutical post-marketing surveillance. PLOS ONE. https://doi.org/10.1371/journal.pone.0289865

Vancouver

Waffo Tchounga CA, Sacré PY, Ravinetto R, Lieberman M, Hamuli Ciza P, Ngono Mballa R, et al. Usefulness of medicine screening tools in the frame of pharmaceutical post-marketing surveillance. PLOS ONE. 2023. doi:10.1371/journal.pone.0289865

BibTeX
@article{WaffoTchounga2023,
  author = {Waffo Tchounga, Christelle Ange and Sacré, Pierre-Yves and Ravinetto, Raffaella and Lieberman, Marya and Hamuli Ciza, Patient and Ngono Mballa, Rose and Ziemons, Eric and Hubert, Philippe and Djang'eing'a Marini, Roland},
  title = {Usefulness of medicine screening tools in the frame of pharmaceutical post-marketing surveillance},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0289865}
}
Kostenlos starten →